Clin2
NCT06835907Possibly a fitRecruiting

Baclofen for anxiety and alcohol use disorder

Alcohol Use Disorder (AUD)

Part of Mental health clinical trials.

This trial tests if baclofen can help people with both anxiety and alcohol use disorder. It is an open-label study, meaning everyone knows they are taking the medication. Researchers want to see if it supports people in staying alcohol-free.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
58 people
Ages
18 years to 65 years
Study type
Interventional

Who can take part

  • You have been diagnosed with alcohol use disorder (AUD).
  • You are able to understand and sign a consent form.
  • You are already taking baclofen or will start it when you enter the hospital.
  • You want to stop drinking alcohol completely.
  • You do not have a serious drug addiction (except for nicotine or cannabis).
  • You do not have unstable mental health or medical conditions that could make baclofen unsafe.
  • You are not pregnant or breastfeeding.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07706660Recruiting
Mindfulness for alcohol use disorder treatment

This trial tests whether adding body-focused mindfulness exercises to standard inpatient treatment can help people with alcohol use disorder. It may improve your ability to manage cravings and prevent relapse.

Warsaw, Mazovian
NCT06636227Recruiting· Phase 1
Diclofenac dose study for alcohol use disorder

This study tests whether different doses of diclofenac, an anti-inflammatory drug, can help people reduce heavy drinking. It looks at how the drug affects drinking patterns and overall health.

Catonsville, Maryland
NCT06580444Not yet recruiting· Phase 2
Study of brexanolone for PTSD and alcohol use in veterans

This trial tests if a drug called brexanolone can help veterans with both PTSD and alcohol use disorder. You will be asked about your drinking and PTSD symptoms, and may receive the drug in a lab setting.

NCT05408247Recruiting· Phase 4
N-acetylcysteine to help people cut back on alcohol

This trial tests whether N-acetylcysteine (a supplement-like medicine) can help people with alcohol use disorder reduce or stop drinking. You may be randomly assigned to receive N-acetylcysteine or a comparison treatment, and you’ll complete interviews during the study.

Sydney, New South Wales
NCT06840652Enrolling by invitation
Baclofen for alcohol withdrawal in liver disease

This trial tests if baclofen, a medicine for alcohol dependence, is safe and works for people with chronic liver disease who are actively drinking. It may help you stop drinking alcohol safely.

Sabadell, Barcelona
NCT05613608Recruiting· Phase 2/Phase 3
Cannabidiol (CBD) study for alcohol use disorder

This trial tests whether cannabidiol (CBD) can help people cut down or quit drinking alcohol. It enrolls adults diagnosed with alcohol use disorder and wanting to reduce drinking, while checking for safety and other mental health or drug use factors.

Aurora, Colorado

Hear when a new Alcohol Use Disorder (AUD) trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.